ATPHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ATPHARMA
Largest movements
- Tangible fixed assets -€37,530
down €37,530 (-4.8%), from €782,341 to €744,810
of which Land and buildings: -€33,032
- Cash +€34,674
up €34,674 (+268%), from €12,935 to €47,609
mainly Net result for the year (+€55,503) and Depreciation (+€37,530)
- Reserves +€110,682
up €110,682 (+423%), from €26,169 to €136,851
of which Distributable reserves: +€110,682
- Debts after one year -€71,265
down €71,265 (-18.9%), from €377,989 to €306,724
- Profit (loss) carried forward -€55,179
no longer reported in 2025 (was €55,179)
- Current portion of long-term debt -€15,107
down €15,107 (-20.3%), from €74,582 to €59,475
- Tax, wage and social debts +€14,154
up €14,154 (+2,270%), from €623 to €14,777
- Gross operating margin +€26,800
up €26,800 (+22.1%), from €121,428 to €148,228
- Taxes +€17,951
up €17,951 (+971%), from €1,849 to €19,800
- Other operating charges -€1,484
down €1,484 (-6.5%), from €22,993 to €21,509
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €799,427 | €792,623 | -€6,804 | -0.9% |
| Fixed assets | 21/28 | €782,341 | €744,810 | -€37,530 | -4.8% |
| Tangible fixed assets | 22/27 | €782,341 | €744,810 | -€37,530 | -4.8% |
| Land and buildings | 22 | €765,485 | €732,453 | -€33,032 | -4.3% |
| Plant, machinery and equipment | 23 | €16,856 | €12,358 | -€4,498 | -26.7% |
| Current assets | 29/58 | €17,086 | €47,812 | +€30,726 | +180% |
| Amounts receivable within one year | 40/41 | €4,151 | - | -€4,151 | |
| Other amounts receivable | 41 | €4,151 | - | -€4,151 | |
| Cash at bank and in hand | 54/58 | €12,935 | €47,609 | +€34,674 | +268% |
| Deferred charges and accrued income | 490/1 | - | €203 | +€203 | |
| Total equity and liabilities | 10/49 | €799,427 | €792,623 | -€6,804 | -0.9% |
| Equity | 10/15 | €142,848 | €198,351 | +€55,503 | +38.9% |
| Contributions | 10/11 | €61,500 | €61,500 | = | 0.0% |
| Capital | 10 | €61,500 | €61,500 | = | 0.0% |
| Issued capital | 100 | €61,500 | €61,500 | = | 0.0% |
| Reserves | 13 | €26,169 | €136,851 | +€110,682 | +423% |
| Non-distributable reserves | 130/1 | €6,150 | €6,150 | = | 0.0% |
| Legal reserve | 130 | €6,150 | €6,150 | = | 0.0% |
| Distributable reserves | 133 | €20,019 | €130,701 | +€110,682 | +553% |
| Profit (loss) carried forward | 14 | €55,179 | - | -€55,179 | |
| Amounts payable | 17/49 | €656,579 | €594,272 | -€62,307 | -9.5% |
| Amounts payable after more than one year | 17 | €377,989 | €306,724 | -€71,265 | -18.9% |
| Financial debts | 170/4 | €377,989 | €306,724 | -€71,265 | -18.9% |
| Amounts payable within one year | 42/48 | €278,590 | €287,549 | +€8,958 | +3.2% |
| Current portion of amounts payable after more than one year | 42 | €74,582 | €59,475 | -€15,107 | -20.3% |
| Trade debts | 44 | €2,356 | €186 | -€2,170 | -92.1% |
| Suppliers | 440/4 | €2,356 | €186 | -€2,170 | -92.1% |
| Advances received on contracts in progress | 46 | - | €9,867 | +€9,867 | |
| Taxes, remuneration and social security | 45 | €623 | €14,777 | +€14,154 | +2,270% |
| Taxes | 450/3 | €623 | €14,777 | +€14,154 | +2,270% |
| Other amounts payable | 47/48 | €201,029 | €203,244 | +€2,214 | +1.1% |
| Non-recurring operating income | 76A | - | €8,304 | +€8,304 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €37,633 | €37,530 | -€103 | -0.3% |
| Other operating charges | 640/8 | €22,993 | €21,509 | -€1,484 | -6.5% |
| Gross operating margin | 9900 | €121,428 | €148,228 | +€26,800 | +22.1% |
| Operating profit (loss) | 9901 | €60,802 | €89,189 | +€28,387 | +46.7% |
| Financial charges | 65/66B | €13,060 | €13,886 | +€826 | +6.3% |
| Recurring financial charges | 65 | €13,060 | €13,886 | +€826 | +6.3% |
| Profit (loss) for the period before taxes | 9903 | €47,742 | €75,303 | +€27,561 | +57.7% |
| Income taxes | 67/77 | €1,849 | €19,800 | +€17,951 | +971% |
| Profit (loss) for the period | 9904 | €45,893 | €55,503 | +€9,610 | +20.9% |
| Profit (loss) for the period to be appropriated | 9905 | €45,893 | €55,503 | +€9,610 | +20.9% |
Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 16 October 2026 via checked.be.